Literature DB >> 6341589

Inhibitors of glycolic acid oxidase. 4-Substituted 3-hydroxy-1H-pyrrole-2,5-dione derivatives.

C S Rooney, W C Randall, K B Streeter, C Ziegler, E J Cragoe, H Schwam, S R Michelson, H W Williams, E Eichler, D E Duggan, E H Ulm, R M Noll.   

Abstract

An extensive series of novel 4-substituted 3-hydroxy-1H-pyrrole-2,5-dione derivatives has been prepared and studied as inhibitors of glycolic acid oxidase (GAO). Compounds possessing large lipophilic 4-substituents are, in general, potent, competitive inhibitors of porcine liver GAO in vitro. Methylation of the nitrogen or the 3-hydroxy substituent reduced potency dramatically, indicating the requirement for the two acidic functions on the 1H-pyrrole-2,5-dione nucleus. In rat liver perfusion studies, with three representative compounds, concentration-dependent inhibition of the conversion of [1-14C]glycolate to [14C]oxalate was observed. Chronic oral administration to ethylene glycol fed rats of the 4-(4'-bromo[1,1'-biphenyl]-4-yl) derivative (83) was shown to effect a significant reduction in urinary oxalate levels over a 58-day period.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6341589     DOI: 10.1021/jm00359a015

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  Metabolism of (13)C5-hydroxyproline in mouse models of Primary Hyperoxaluria and its inhibition by RNAi therapeutics targeting liver glycolate oxidase and hydroxyproline dehydrogenase.

Authors:  Xingsheng Li; John Knight; Sonia Fargue; Brianna Buchalski; Zhengrong Guan; Edward W Inscho; Abigail Liebow; Kevin Fitzgerald; William Querbes; W Todd Lowther; Ross P Holmes
Journal:  Biochim Biophys Acta       Date:  2015-12-02

2.  Three-dimensional structures of glycolate oxidase with bound active-site inhibitors.

Authors:  K Stenberg; Y Lindqvist
Journal:  Protein Sci       Date:  1997-05       Impact factor: 6.725

3.  Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.

Authors:  Sabrina R Mackinnon; Gustavo A Bezerra; Tobias Krojer; Tamas Szommer; Frank von Delft; Paul E Brennan; Wyatt W Yue
Journal:  Front Chem       Date:  2022-05-04       Impact factor: 5.545

4.  Structure of human glycolate oxidase in complex with the inhibitor 4-carboxy-5-[(4-chlorophenyl)sulfanyl]-1,2,3-thiadiazole.

Authors:  Jean Marie Bourhis; Caroline Vignaud; Nicolas Pietrancosta; Françoise Guéritte; Daniel Guénard; Florence Lederer; Ylva Lindqvist
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-11-27

Review 5.  Lowering urinary oxalate excretion to decrease calcium oxalate stone disease.

Authors:  Ross P Holmes; John Knight; Dean G Assimos
Journal:  Urolithiasis       Date:  2015-11-27       Impact factor: 3.436

6.  Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds.

Authors:  J Tomassini; H Selnick; M E Davies; M E Armstrong; J Baldwin; M Bourgeois; J Hastings; D Hazuda; J Lewis; W McClements
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

7.  Dual Glycolate Oxidase/Lactate Dehydrogenase A Inhibitors for Primary Hyperoxaluria.

Authors:  Jinyue Ding; Rajesh Gumpena; Marc-Olivier Boily; Alexandre Caron; Oliver Chong; Jennifer H Cox; Valerie Dumais; Samuel Gaudreault; Aaron H Graff; Andrew King; John Knight; Renata Oballa; Jayakumar Surendradoss; Tim Tang; Joyce Wu; W Todd Lowther; David A Powell
Journal:  ACS Med Chem Lett       Date:  2021-05-20       Impact factor: 4.632

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.